Navigation Links
Wistar receives $4.7 million to develop drug against Epstein-Barr virus-related cancers
Date:12/15/2011

expressed consistently in all EBV-related cancer and is essential for the virus to reproduce," said Lieberman. "Knocking out EBNA1, therefore, could likely eliminate latent Epstein-Barr virus and control the growth of EBV-associated cancer."

Lieberman heads Wistar's Center for Chemical Biology and Translational Medicine, a team of researchers whose mission is to develop promising basic research findings into new therapeutics to fight disease, particularly cancer.

To develop an anti-EBV drug, the researchers began a complex screening process to find a small molecule that could chemically bind to EBNA1 and inhibit its ability to function. They began with a library of 600,000 molecular compounds, eventually narrowing the pool down through a series of tests to a handful of leading candidate molecules that have the most potential to serve as the basis of new anti-EBV drug.

With funds from the Wellcome Trust, the Wistar researchers will further optimize their candidate small molecule inhibitors, with the aim of developing at least one chemical compound into a viable drug candidate. This drug candidate could then be used in clinical trials designed to determine its safety and effectiveness for humans.

"This is an investment in drug discovery, enabling a small team of experts to do the type of translational research typically seen in large drug companies," said Messick. "If successful with the translational research funded by the Wellcome Trust, the program will be in a position to attract a commercial partner to undertake further clinical development."
'/>"/>

Contact: Greg Lester
glester@wistar.org
215-898-3943
The Wistar Institute
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Wistar researchers: Direct proof of how T cells stay in standby mode
2. Wistar researchers follow a path to a potential therapy for NF2, a rare tumor disorder
3. Wistar researchers discover new class of objects encoded within the genome
4. Wistar scientists explain the persistence of melanoma through dynamic stemness
5. Northwestern receives $10 million gift for life sciences graduates
6. RI Hospital receives $1.5 million grant to study treatments for body dysmorphic disorder
7. Thomas Jefferson University receives Science Centers QED Award for pancreatic cancer research
8. BMC resident receives American Society for Clinical Pathology awards
9. R. Michael Scott, M.D., receives the Franc D. Ingraham Distinguished Service Award
10. Kessler Foundation receives grant to study cognitive reserve in traumatic brain injury
11. Kessler Foundation receives grants to study health disparities in people with disabilities
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Wistar receives $4.7 million to develop drug against Epstein-Barr virus-related cancers
(Date:8/27/2015)... ... August 27, 2015 , ... Allegheny General Hospital ... 20 adult-only medical centers in the United States to receive international recognition for ... The Extracorporeal Life Support Organization (ELSO) , an international consortium of healthcare ...
(Date:8/27/2015)... ... August 27, 2015 , ... About 10 percent ... into the Gulf Coast, killing more than 1,800 people, displacing hundreds of thousands ... Georgia State University study. , While most people don’t develop persistent depression after ...
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... ... & IoT Summit , scheduled for October 27-29, 2015 in San Jose, CA. ... the summit will primarily focus on the void that exists where battery development ...
(Date:8/27/2015)... ... August 27, 2015 , ... Zensah®, the premium ... Tennis player for Israel in the Women’s Tennis Association (WTA). Glushko competes in ... and recovery. , With a focus on technology and comfort, Zensah® has developed ...
(Date:8/27/2015)... CITY, Tenn. (PRWEB) , ... August 27, 2015 , ... ... LLC, DBA All Clear System. The agreement will enable both Johnson City, Tenn.-based firms ... All Clear System is a cloud-based safety product that caters to organizations in the ...
Breaking Medicine News(10 mins):Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4Health News:About 10 Percent of Mothers Experienced Depression Two Years After Hurricane Katrina, New Study Shows 2Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 2Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 2Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 4
... Ind., Feb. 27 Zimmer Holdings, Inc. (NYSE: ... N. Casper, Executive Vice President and Chief Operating Officer ... its Board of Directors. Thermo Fisher Scientific, the ... equipment, supplies and services used in life sciences, healthcare, ...
... System, as Inventor of the Month for February 2009SAN ... ADSK ) has named Cochlear Bone Anchored Solutions, a ... in the development and manufacturing of implantable hearing solutions, ... February 2009.Cochlear successfully used Autodesk Inventor software ...
... by Communion and Liberation: D A T E: Friday, February 27, 2009 ... Gowan Hall ( Nursing-Biology Building ), ... 620 Michigan Avenue NE , Washington , ... Different Way of Facing H.I.V. -- From Sickness and Despair to a New Life: ...
... a Highly Effective and Affordable New Option to Help ... Derma Sciences, Inc. (OTC Bulletin ... announced today that its first BIOGUARD Barrier Dressings have ... for marketing and distribution. BIOGUARD will offer surgeons, ...
... Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical ... company,s premier dental pharmaceutical product. OraVerse is the ... accelerates the return to normal sensation and function ... and unnecessary lingering soft tissue anesthesia following routine ...
... University of Pittsburgh Medical Center (UPMC) and Paphos Plantations Ltd. (PPL) - ... collaborating to develop a world-class health care center in Paphos, Cyprus, designed ... and foreign visitors to this Mediterranean island. , ... Pittsburgh, PA and ...
Cached Medicine News:Health News:Zimmer Holdings Names Marc Casper to Board of Directors 2Health News:Zimmer Holdings Names Marc Casper to Board of Directors 3Health News:Superior Sound Amplifies Quality of Life for the Deaf and Hard of Hearing 2Health News:Superior Sound Amplifies Quality of Life for the Deaf and Hard of Hearing 3Health News:Superior Sound Amplifies Quality of Life for the Deaf and Hard of Hearing 4Health News:Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology 2Health News:Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology 3Health News:Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology 4Health News:Video: Novalar Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent 2Health News:Video: Novalar Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent 3Health News:Video: Novalar Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent 4Health News:University of Pittsburgh Medical Center to Manage New Health Center in Cyprus 2Health News:University of Pittsburgh Medical Center to Manage New Health Center in Cyprus 3Health News:University of Pittsburgh Medical Center to Manage New Health Center in Cyprus 4
(Date:8/27/2015)... , August 27, 2015 According ... Market by Type (Integrated, Standalone), by Deployment Mode (Web ... Physicians, Emergency Healthcare Service Providers), by Component - Global ... Systems Market is estimated at $501.1 Million 2014, and ... a CAGR of 7.6% from 2014 to 2019. ...
(Date:8/27/2015)... 2015  BioElectronics Corporation (OTC Pink: BIEL), the maker ... abstracts featuring the use of ActiPatch®, its novel musculoskeletal ... Congress of the European Pain Federation EFIC®, ... 2015. The Company will also be exhibiting at the ... Bagnato , department clinical and experimental rheumatology from the ...
(Date:8/27/2015)... --  Americord Registry , a private cord blood ... banking company, announced today the launch of their ... website makes the expecting parent,s cord blood banking purchase ... checkout process. Logo - http://photos.prnewswire.com/prnh/20150827/261520LOGO ... this service difficult to purchase online. We want to ...
Breaking Medicine Technology:Radiology Information Systems Market Worth $722.7 Million by 2019 2Radiology Information Systems Market Worth $722.7 Million by 2019 3Radiology Information Systems Market Worth $722.7 Million by 2019 4BioElectronics Selected to Present its Pain Research and Devices at the European Pain Federation Conference 2Cord Blood Bank Revolutionizes Process of Online Cord Blood Banking 2
... Va., Nov. 16 As a two-time cancer survivor, Bill Still ... Sentara Cancer Network first-hand. When Bill,s prostate cancer ... group with the help of a community outreach nurse at Sentara ... care delivery system, he was largely on his own. , Bill ...
... , MAPLE GROVE, Minn., Nov. 16 ... Treatment of L ipoproteins and I nflammatory ... Journal of Clinical Lipidology . The objective was to ... and Lipitor (atorvastatin calcium) 10 mg/day, given alone and then ...
Cached Medicine Technology:Sentara Cancer Network Earns National Accreditation 2New Data: Cholesterol Management Analysis of Upsher-Smith's Slo-Niacin(R) Tablets in Combination with Lipitor(R) 2New Data: Cholesterol Management Analysis of Upsher-Smith's Slo-Niacin(R) Tablets in Combination with Lipitor(R) 3New Data: Cholesterol Management Analysis of Upsher-Smith's Slo-Niacin(R) Tablets in Combination with Lipitor(R) 4
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The ACMI™ line of laparoscopic hand instruments is designed to provide a wide selection of popular surgical devices to meet procedural needs....
This probe coagulates bleeders while suction channel with trumpet valve simultaneously evacuates smoke....
Bair Hugger temperature management units are the only forced-air warming systems that can be used with an integrated, cost-effective method of fluid warming...
Medicine Products: